z-logo
open-access-imgOpen Access
Is phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway therapeutic target for esophageal adenocarcinoma
Author(s) -
Kazuto Harada,
Shumei Song,
Hideo Baba,
Jaffer A. Ajani
Publication year - 2017
Publication title -
shanghai chest
Language(s) - English
Resource type - Journals
ISSN - 2521-3768
DOI - 10.21037/shc.2017.10.07
Subject(s) - pi3k/akt/mtor pathway , protein kinase b , phosphatidylinositol , cancer research , esophageal adenocarcinoma , kinase , adenocarcinoma , signal transduction , medicine , microbiology and biotechnology , biology , cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here